Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	heart development	EPOR SIN3B PDLIM7 SPEG PKD1L1 ABCC9 TSC2 PLXND1 MESP1 KIF7 ADGRG6 THBS1 HEG1 GRK2 ADAMTS9 ACAN ROBO1 HECTD1	7.68e-06	757	147	18	GO:0007507
GeneOntologyBiologicalProcess	coronary vasculature development	EPOR ABCC9 PLXND1 MESP1 KIF7 ROBO1	2.84e-05	83	147	6	GO:0060976
GeneOntologyCellularComponent	axon	CNTNAP3B ANK3 MYOC ESR1 RTN4R INSRR CNTNAP3 GRIA1 GRIA3 TSC2 PLXND1 CDKL5 GRK2 SYNJ1 IGHMBP2 AP3B2 ROBO1	2.92e-04	891	153	17	GO:0030424
GeneOntologyCellularComponent	extracellular matrix	MYOC ADAMTS13 SSPOP THBS1 IGFBP7 ADAMTS9 P3H2 ACAN NCAN ELANE C1QB DMBT1 ADAMTS14 ADAMTSL4	3.39e-04	656	153	14	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	MYOC ADAMTS13 SSPOP THBS1 IGFBP7 ADAMTS9 P3H2 ACAN NCAN ELANE C1QB DMBT1 ADAMTS14 ADAMTSL4	3.50e-04	658	153	14	GO:0030312
GeneOntologyCellularComponent	cell surface	EPOR STAB2 ANK3 RTN4R GRIA1 ADAMTS13 THSD1 GFRA3 ADGRG6 THBS1 HEG1 CD6 MSLNL ADAMTS9 MRC2 ELANE ROBO1 TREML1 CXCR1	4.98e-04	1111	153	19	GO:0009986
GeneOntologyCellularComponent	collagen-containing extracellular matrix	MYOC SSPOP THBS1 IGFBP7 ADAMTS9 P3H2 ACAN NCAN ELANE C1QB DMBT1 ADAMTSL4	5.41e-04	530	153	12	GO:0062023
MousePheno	abnormal bronchus epithelium morphology	ANK3 HGSNAT THBS1 ROBO1	2.34e-06	12	119	4	MP:0010943
Domain	TSP_1	ADAMTS13 THSD1 SSPOP THBS1 ADAMTS9 ADAMTS14 RSPO1 ADAMTSL4	3.10e-08	63	146	8	PF00090
Domain	TSP1	ADAMTS13 THSD1 SSPOP THBS1 ADAMTS9 ADAMTS14 RSPO1 ADAMTSL4	3.98e-08	65	146	8	SM00209
Domain	TSP1_rpt	ADAMTS13 THSD1 SSPOP THBS1 ADAMTS9 ADAMTS14 RSPO1 ADAMTSL4	3.98e-08	65	146	8	IPR000884
Domain	TSP1	ADAMTS13 THSD1 SSPOP THBS1 ADAMTS9 ADAMTS14 RSPO1 ADAMTSL4	3.98e-08	65	146	8	PS50092
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	ADAMTS13 THSD1 SSPOP THBS1 ADAMTS9 ADAMTS14 ADAMTSL4	2.63e-08	39	116	7	M27417
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	ADAMTS13 THSD1 SSPOP THBS1 ADAMTS9 ADAMTS14 ADAMTSL4	2.63e-08	39	116	7	MM15165
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	ADAMTS13 THSD1 SSPOP THBS1 ADAMTS9 ADAMTS14 ADAMTSL4	1.36e-06	68	116	7	M27303
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	ADAMTS13 THSD1 SSPOP THBS1 ADAMTS9 ACAN NCAN ADAMTS14 ADAMTSL4	2.68e-06	143	116	9	M27275
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	ADAMTS13 THSD1 SSPOP THBS1 ADAMTS9 ADAMTS14 ADAMTSL4	3.18e-05	109	116	7	MM15164
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	ADAMTS13 THSD1 SSPOP THBS1 ADAMTS9 ADAMTS14 ADAMTSL4	3.57e-05	111	116	7	M27416
Pathway	REACTOME_DISEASES_OF_METABOLISM	HGSNAT ADAMTS13 THSD1 SSPOP THBS1 ADAMTS9 ACAN NCAN ADAMTS14 ADAMTSL4	4.04e-05	250	116	10	M27554
Pubmed	Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes.	SP1 ESR1 ARNT	3.67e-07	4	158	3	9611253
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	ADAMTS13 SSPOP THBS1 ADAMTS9 ADAMTS14 ADAMTSL4	1.24e-06	75	158	6	20637190
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	PKD1L1 PLXND1 KIF7 ACAN ROBO1 HECTD1	6.70e-06	100	158	6	25807483
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 MPP3 SPEG TSC2 PLXND1 DHX30 RHPN1 CELSR1 HEG1 KANSL1 SYNJ1 ARVCF IL17RE NFX1 HECTD1 PRRC2B SMG6	1.24e-05	1105	158	17	35748872
Pubmed	Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3.	GRIA1 GRIA3	2.05e-05	2	158	2	27708157
Pubmed	Estrogen regulates KiSS1 gene expression through estrogen receptor alpha and SP protein complexes.	SP1 ESR1	2.05e-05	2	158	2	17656465
Pubmed	Estrogen-ERα signaling and DNA hypomethylation co-regulate expression of stem cell protein PIWIL1 in ERα-positive endometrial cancer cells.	ESR1 PIWIL1	2.05e-05	2	158	2	32503542
Pubmed	Motor Learning Requires Purkinje Cell Synaptic Potentiation through Activation of AMPA-Receptor Subunit GluA3.	GRIA1 GRIA3	2.05e-05	2	158	2	28103481
Pubmed	Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.	CNTNAP3B CNTNAP3	2.05e-05	2	158	2	26807827
Pubmed	SYNJ1 rescues motor functions in hereditary and sporadic Parkinson's disease mice by upregulating TSP-1 expression.	THBS1 SYNJ1	2.05e-05	2	158	2	37419331
Pubmed	Distinct effects of AMPAR subunit depletion on spatial memory.	GRIA1 GRIA3	2.05e-05	2	158	2	37876813
Pubmed	Functional synergy between the transcription factor Sp1 and the estrogen receptor.	SP1 ESR1	2.05e-05	2	158	2	9328340
Pubmed	Multiple effects of artemin on sympathetic neurone generation, survival and growth.	ARTN GFRA3	2.05e-05	2	158	2	11585795
Pubmed	Transcription factor-pathway coexpression analysis reveals cooperation between SP1 and ESR1 on dysregulating cell cycle arrest in non-hyperdiploid multiple myeloma.	SP1 ESR1	2.05e-05	2	158	2	23925045
Pubmed	A novel function of R-spondin1 in regulating estrogen receptor expression independent of Wnt/β-catenin signaling.	ESR1 RSPO1	2.05e-05	2	158	2	32749219
Pubmed	Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex.	ARTN GFRA3	2.05e-05	2	158	2	9883723
Pubmed	Synaptic plasticity through activation of GluA3-containing AMPA-receptors.	GRIA1 GRIA3	2.05e-05	2	158	2	28762944
Pubmed	The critical role of ASD-related gene CNTNAP3 in regulating synaptic development and social behavior in mice.	CNTNAP3B CNTNAP3	2.05e-05	2	158	2	31150793
Pubmed	The endocytic receptor uPARAP is a regulator of extracellular thrombospondin-1.	THBS1 MRC2	2.05e-05	2	158	2	35878760
Pubmed	Common variants in the regulative regions of GRIA1 and GRIA3 receptor genes are associated with migraine susceptibility.	GRIA1 GRIA3	2.05e-05	2	158	2	20579352
Pubmed	Estrogen receptor α (ESR1) over-expression mediated apoptosis in Hep3B cells by binding with SP1 proteins.	SP1 ESR1	2.05e-05	2	158	2	23733894
Pubmed	Enhanced artemin/GFRα3 levels regulate mechanically insensitive, heat-sensitive C-fiber recruitment after axotomy and regeneration.	ARTN GFRA3	2.05e-05	2	158	2	21123573
Pubmed	Structure of artemin complexed with its receptor GFRalpha3: convergent recognition of glial cell line-derived neurotrophic factors.	ARTN GFRA3	2.05e-05	2	158	2	16765900
Pubmed	Localization of blood proteins thrombospondin1 and ADAMTS13 to cerebral corpora amylacea.	ADAMTS13 THBS1	2.05e-05	2	158	2	19422532
Pubmed	hsa_circ_0007919 promotes pancreatic cancer metastasis by modulating Sp1-mediated THBS1 transcription.	SP1 THBS1	2.05e-05	2	158	2	38572579
Pubmed	Estrogen-induced smooth muscle cell growth is regulated by tuberin and associated with altered activation of platelet-derived growth factor receptor-beta and ERK-1/2.	ESR1 TSC2	2.05e-05	2	158	2	15039427
Pubmed	Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer.	SP1 ESR1	2.05e-05	2	158	2	15637147
Pubmed	The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding.	SP1 ARNT	2.05e-05	2	158	2	16410262
Pubmed	[Artemin and GFRalpha3 expressions and their relevance to perineural invasiveness and metastasis of pancreatic carcinoma].	ARTN GFRA3	2.05e-05	2	158	2	19304517
Pubmed	A pathway-specific function for different AMPA receptor subunits in amygdala long-term potentiation and fear conditioning.	GRIA1 GRIA3	2.05e-05	2	158	2	17928436
Pubmed	EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.	EPOR ESR1	2.05e-05	2	158	2	24502950
Pubmed	Novel ADAMTSL4 gene mutations in Chinese patients with isolated ectopia lentis.	THBS1 ADAMTSL4	2.05e-05	2	158	2	35042684
Pubmed	[Correlation of serum ADAMTS13 and TSP1 levels with myocardial injury and prognosis in patients with acute coronary syndrome].	ADAMTS13 THBS1	2.05e-05	2	158	2	34134958
Pubmed	SP1-induced lncRNA DANCR contributes to proliferation and invasion of ovarian cancer.	SP1 DANCR	2.05e-05	2	158	2	33089960
Pubmed	Sp1 transcription factor is a modulator of estradiol leptin induction in placental cells.	SP1 ESR1	2.05e-05	2	158	2	28864005
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	TSC2 FAM120AOS MBIP SHKBP1 PAOX FBH1 TRMT44 CDCA7 ARMC5 C8orf82 NECAB3 MIEF1 DMBT1 ZNF598 DHX29	2.27e-05	925	158	15	28986522
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ANK3 CCT3 ACOT7 GRIA1 NBEA JMY DHX30 CDKL5 CRACD GRK2 SYNJ1 ARVCF NCAN AP3B2 C1QB RIMS1 DHX29 PRRC2B PTCD3	2.90e-05	1431	158	19	37142655
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SIN3B ANK3 CCT3 TBC1D5 GRIA1 GRIA3 NBEA TSC2 KIF7 SYNJ1 ARVCF NCAN RIMS1 PRRC2B SMG6	3.60e-05	963	158	15	28671696
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	PDLIM7 TBC1D5 NBEA SYNJ1 MRC2 AP3B2 AGFG2 STX16	5.13e-05	285	158	8	34369648
Pubmed	Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.	ESR1 THSD1 THBS1 MRC2 NCAN DMBT1 RSPO1	5.22e-05	210	158	7	16537572
Pubmed	Transcriptional regulation of human cyclic GMP-AMP synthase gene.	SP1 CGAS	6.13e-05	3	158	2	31276766
Pubmed	Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites.	SP1 ESR1	6.13e-05	3	158	2	15084343
Pubmed	AMPA receptor anchoring at CA1 synapses is determined by N-terminal domain and TARP γ8 interactions.	GRIA1 GRIA3	6.13e-05	3	158	2	34426577
Pubmed	Estrogen Receptor 1 (ESR1) Enhances Slc2a4/GLUT4 Expression by a SP1 Cooperative Mechanism.	SP1 ESR1	6.13e-05	3	158	2	30275758
Pubmed	Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage.	GRIA1 GRIA3	6.13e-05	3	158	2	15144856
Pubmed	The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.	ESR1 ARNT	6.13e-05	3	158	2	10619402
Pubmed	Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro.	ADAMTS13 THBS1	6.13e-05	3	158	2	20705333
Pubmed	Glutamate receptor subunit 3 is modified by site-specific limited proteolysis including cleavage by gamma-secretase.	GRIA1 GRIA3	6.13e-05	3	158	2	12700243
Pubmed	Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.	GRIA1 GRIA3	6.13e-05	3	158	2	12172541
Pubmed	Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.	SP1 ESR1	6.13e-05	3	158	2	17717078
Pubmed	Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements.	SP1 ESR1	6.13e-05	3	158	2	10681512
Pubmed	Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase.	THBS1 ELANE	6.13e-05	3	158	2	8463250
Pubmed	In vitro localization of TIGR/MYOC in trabecular meshwork extracellular matrix and binding to fibronectin.	MYOC THBS1	6.13e-05	3	158	2	11773026
Pubmed	An interactive network of elastase, secretases, and PAR-2 protein regulates CXCR1 receptor surface expression on neutrophils.	ELANE CXCR1	6.13e-05	3	158	2	24914212
Pubmed	Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory.	ESR1 GRIA1	6.13e-05	3	158	2	18297067
Pubmed	Novel roles for AhR and ARNT in the regulation of alcohol dehydrogenases in human hepatic cells.	ADH1B ARNT	6.13e-05	3	158	2	27055685
Pubmed	Doxorubicin influences the expression of glucosylceramide synthase in invasive ductal breast cancer.	SP1 ESR1	6.13e-05	3	158	2	23133636
Pubmed	Subunit-specific role for the amino-terminal domain of AMPA receptors in synaptic targeting.	GRIA1 GRIA3	6.13e-05	3	158	2	28630296
Pubmed	Gonadotropin-releasing hormone-mediated phosphorylation of estrogen receptor-alpha contributes to fosB expression in mouse gonadotrophs.	ESR1 TAF6L	6.13e-05	3	158	2	19574399
Pubmed	NMDAR-dependent presynaptic homeostasis in adult hippocampus: Synapse growth and cross-modal inhibitory plasticity.	GRIA1 GRIA3	6.13e-05	3	158	2	36070750
Pubmed	Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation.	SP1 ESR1	6.13e-05	3	158	2	22213398
Pubmed	An inhalation anaesthesia approach for neonatal mice allowing streamlined stereotactic injection in the brain.	GRIA1 GRIA3	6.13e-05	3	158	2	32569783
Pubmed	Long-term potentiation reconstituted with an artificial TARP/PSD-95 complex.	GRIA1 GRIA3	6.13e-05	3	158	2	36223737
Pubmed	Persistent synaptic scaling independent of AMPA receptor subunit composition.	GRIA1 GRIA3	6.13e-05	3	158	2	23864664
Pubmed	Autocrine regulation of early embryonic development by the artemin-GFRA3 (GDNF family receptor-alpha 3) signaling system in mice.	ARTN GFRA3	6.13e-05	3	158	2	19580811
Pubmed	17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells.	SP1 ESR1	6.13e-05	3	158	2	20052536
Pubmed	Regulation of constitutive gene expression through interactions of Sp1 protein with the nuclear aryl hydrocarbon receptor complex.	SP1 ARNT	6.13e-05	3	158	2	10471301
Pubmed	Evaluating von Willebrand factor and ADAMTS13 levels in thalassemia major patients and assessing a possible association with Thrombospondin-1.	ADAMTS13 THBS1	6.13e-05	3	158	2	37438087
Pubmed	Involvement of aryl hydrocarbon receptor nuclear translocator in EGF-induced c-Jun/Sp1-mediated gene expression.	SP1 ARNT	6.13e-05	3	158	2	20508969
Pubmed	ER alpha-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription.	ESR1 ARNT	6.13e-05	3	158	2	15837795
Pubmed	Myocilin is involved in NgR1/Lingo-1-mediated oligodendrocyte differentiation and myelination of the optic nerve.	MYOC RTN4R	6.13e-05	3	158	2	24741044
Pubmed	Estrogen receptor-alpha and Sp1 interact in the induction of the low density lipoprotein-receptor.	SP1 ESR1	6.13e-05	3	158	2	14568562
Pubmed	Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions.	SP1 ESR1	6.13e-05	3	158	2	10446910
Pubmed	AMPA receptor alterations precede mossy fiber sprouting in young children with temporal lobe epilepsy.	GRIA1 GRIA3	6.13e-05	3	158	2	15145077
Pubmed	The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.	SP1 ESR1	6.13e-05	3	158	2	12612060
Pubmed	Synaptic transmission and plasticity require AMPA receptor anchoring via its N-terminal domain.	GRIA1 GRIA3	6.13e-05	3	158	2	28290985
Pubmed	Long-term upregulation of cortical glutamatergic AMPA receptors in a mouse model of chronic visceral pain.	GRIA1 GRIA3	6.13e-05	3	158	2	26585043
Pubmed	Glutamatergic plasticity by synaptic delivery of GluR-B(long)-containing AMPA receptors.	GRIA1 GRIA3	6.13e-05	3	158	2	14687553
Pubmed	Synaptic homeostasis requires the membrane-proximal carboxy tail of GluA2.	GRIA1 GRIA3	6.13e-05	3	158	2	29180434
Pubmed	Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins.	SP1 ESR1	6.13e-05	3	158	2	10816575
Pubmed	Gata4 and Sp1 regulate expression of the erythropoietin receptor in cardiomyocytes.	EPOR SP1	6.13e-05	3	158	2	21029371
Pubmed	Synaptic AMPA receptor plasticity and behavior.	GRIA1 GRIA3	6.13e-05	3	158	2	19217372
Pubmed	The transcriptional modulator Ifrd1 controls PGC-1α expression under short-term adrenergic stimulation in brown adipocytes.	SP1 SIN3B	6.13e-05	3	158	2	28107769
Pubmed	Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach.	GRIA1 GRIA3	6.13e-05	3	158	2	19409270
Pubmed	Synaptic targeting of AMPA receptors is regulated by a CaMKII site in the first intracellular loop of GluA1.	GRIA1 GRIA3	6.13e-05	3	158	2	21135237
Pubmed	LTP requires a reserve pool of glutamate receptors independent of subunit type.	GRIA1 GRIA3	6.13e-05	3	158	2	23235828
Pubmed	Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells.	SP1 ESR1	6.13e-05	3	158	2	16675542
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	SIN3B MAGI3 CFB DHX30 THBS1 KANSL1 SYNJ1 NFX1 DHX29 PRRC2B	6.80e-05	475	158	10	31040226
Pubmed	Misregulation of an Activity-Dependent Splicing Network as a Common Mechanism Underlying Autism Spectrum Disorders.	NBEA SYNJ1 ARVCF	7.14e-05	18	158	3	27984743
Pubmed	A microarray analysis of the XX Wnt4 mutant gonad targeted at the identification of genes involved in testis vascular differentiation.	SOSTDC1 IGFBP7 ROBO1	8.45e-05	19	158	3	16844427
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	SIN3B CCT3 TBC1D5 ACOT7 WAC DHX30 RASSF5 CRACD DDX50 SYNJ1 BOD1L1 ZNF598 DHX29 PRRC2B	9.91e-05	934	158	14	33916271
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	SP1 SIN3B SPTLC2 TSC2 SAPCD2 WAC DHX30 TAF6L CRACD GTPBP2 ARNT ADO TRMT44 PIGH ARMC5 HECTD1 ZNF415	1.20e-04	1327	158	17	32694731
Pubmed	Artemin, a glial cell line-derived neurotrophic factor family member, induces TRPM8-dependent cold pain.	ARTN GFRA3	1.22e-04	4	158	2	23884957
Pubmed	Binding of the ERα and ARNT1 AF2 domains to exon 21 of the SRC1 isoform SRC1e is essential for estrogen- and dioxin-related transcription.	ESR1 ARNT	1.22e-04	4	158	2	22328528
Pubmed	The mitochondrial fission receptor MiD51 requires ADP as a cofactor.	ESR1 MIEF1	1.22e-04	4	158	2	24508339
Pubmed	AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus.	GRIA1 GRIA3	1.22e-04	4	158	2	9221927
Pubmed	Interaction proteomics reveals brain region-specific AMPA receptor complexes.	GRIA1 GRIA3	1.22e-04	4	158	2	25337787
Pubmed	Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors.	GRIA1 GRIA3	1.22e-04	4	158	2	17828255
Pubmed	The N-terminal domain modulates α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor desensitization.	GRIA1 GRIA3	1.22e-04	4	158	2	24652293
Pubmed	Modulation of oestrogen receptor signalling by association with the activated dioxin receptor.	ESR1 ARNT	1.22e-04	4	158	2	12774124
Interaction	IGHMBP2 interactions	ESR1 CGAS CDKL5 IGHMBP2 ROBO1 HECTD1	6.51e-07	41	154	6	int:IGHMBP2
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS13 ADAMTS9 ADAMTS14	1.28e-04	19	95	3	50
GeneFamily	PDZ domain containing	MPP3 PDLIM7 PARD6G MAGI3 RHPN1 RIMS1	1.50e-04	152	95	6	1220
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	ACAN NCAN	1.63e-04	4	95	2	574
GeneFamily	Glutamate ionotropic receptor AMPA type subunits	GRIA1 GRIA3	1.63e-04	4	95	2	1200
GeneFamily	DEAH-box helicases	DHX30 DHX29	3.12e-03	16	95	2	500
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CFB ACAN NCAN	3.35e-03	57	95	3	1179
Coexpression	IVANOVA_HEMATOPOIESIS_MATURE_CELL	EPOR SH3TC2 STAB2 HGSNAT M1AP THBS1 GTPBP2 SYNJ1 C1QB HECTD1	1.33e-05	298	157	10	M11205
Coexpression	IVANOVA_HEMATOPOIESIS_MATURE_CELL	EPOR SH3TC2 STAB2 HGSNAT M1AP THBS1 GTPBP2 SYNJ1 C1QB HECTD1	2.27e-05	317	157	10	MM1163
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	EPOR PDLIM7 THBS1 ADO STX16	2.79e-05	59	157	5	M15844
Coexpression	GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP	SP1 SIN3B TBC1D5 HGSNAT GTPBP2 DCAF17 GARRE1 PHLPP2	2.89e-05	200	157	8	M4440
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 MAGI3 MBIP RHPN1 CELSR1 TMEM132D IL17RE RIMS1	1.27e-07	162	159	8	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDLIM7 ABCC9 ARTN RRAD IGFBP7 ADAMTS9 ACAN NEURL1B	4.29e-07	190	159	8	d6b3a92119b210974a32af3fe9875d60eb02761e
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	PDLIM7 SPEG ARTN RRAD IGFBP7 ADAMTS9 ACAN NEURL1B	4.47e-07	191	159	8	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122\|Adult / Lineage, Cell type, age group and donor	CNTNAP3B HRCT1 CNTNAP3 PARD6G THSD1 IGFBP7 ADAMTS9	3.00e-06	173	159	7	dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	INSRR ADH1B IGFBP7 MRC2 ELANE ROBO1 ADAMTSL4	3.76e-06	179	159	7	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP3 SH3TC2 STAB2 PLXND1 THSD1 IGFBP7 ROBO1	4.35e-06	183	159	7	709a486154b3157427deb3b8886b63ac39ea42dd
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDLIM7 CNTNAP3 SOSTDC1 FJX1 RRAD KLHL31 AOPEP	4.35e-06	183	159	7	6b5eef96b28911c752a8b6c0975918c4572cec38
ToppCell	droplet-Liver-nan-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP3 SH3TC2 STAB2 PLXND1 THSD1 IGFBP7 ROBO1	4.35e-06	183	159	7	dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 SOSTDC1 GRIA3 GFRA3 TAF6L P3H2 NECAB3	4.35e-06	183	159	7	8330c39184ce076e1f95fd3725b68af551d89db0
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI3 MBIP CDKL5 CELSR1 TMEM132D IL17RE P3H2	4.51e-06	184	159	7	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-T_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IMPA2 RTN4R ACOT7 SOSTDC1 GRIA3 CDCA7 ELANE	4.51e-06	184	159	7	185b49630da61cbf45c0926d1b992943296d2a54
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 PDLIM7 SPEG SOSTDC1 RRAD ADGRG6 RIMS1	4.84e-06	186	159	7	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCC9 FJX1 RRAD IGFBP7 ADAMTS9 ACAN NEURL1B	4.84e-06	186	159	7	1e3ab663e4756975db6d802b2c6c054a94a79393
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Lymphocytic\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IMPA2 RTN4R ACOT7 SOSTDC1 GRIA3 CDCA7 ELANE	5.01e-06	187	159	7	e53471c3e146a6f54788d81ecc469aba55b051bb
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCC9 FJX1 RRAD IGFBP7 ADAMTS9 ACAN NEURL1B	5.01e-06	187	159	7	b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IMPA2 RTN4R ACOT7 SOSTDC1 GRIA3 CDCA7 ELANE	5.01e-06	187	159	7	3d7d51fbadb20dc884d0b3c0d61b80f022b19d09
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	IMPA2 ABCC9 RRAD ADGRG6 IGFBP7 ADAMTS9 ADAMTS14	5.01e-06	187	159	7	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	390C-Endothelial_cells-Endothelial-F_(Lymphatics)\|390C / Donor, Lineage, Cell class and subclass (all cells)	CNTNAP3B STAB2 HRCT1 CNTNAP3 PARD6G THSD1 ADAMTS9	5.19e-06	188	159	7	aa69e3f44d506f5ef358a3374ac5160d847c858f
ToppCell	Endothelial-endothelial_cell_of_lymph_vessel\|World / Lineage, Cell type, age group and donor	CNTNAP3B STAB2 CNTNAP3 PARD6G THSD1 IGFBP7 ADAMTS9	5.19e-06	188	159	7	80910dcbb51990f2baed240f319456c0d3fa2065
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 PDLIM7 SPEG SOSTDC1 RRAD ADGRG6 RIMS1	5.19e-06	188	159	7	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	390C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	CNTNAP3B STAB2 HRCT1 CNTNAP3 PARD6G THSD1 ADAMTS9	5.19e-06	188	159	7	1f40b959777d18ad88d239df8cca304f062ba04c
ToppCell	COVID-19-lung-Lymphatic_EC\|lung / Disease (COVID-19 only), tissue and cell type	CNTNAP3B STAB2 HRCT1 CNTNAP3 PARD6G IGFBP7 ADAMTS9	5.38e-06	189	159	7	c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	IMPA2 RCSD1 ADGRG6 IGFBP7 ADAMTS9 P3H2 ACAN	5.38e-06	189	159	7	9c407b17d7945e81e1ae6c18452f5d20fb09d563
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	IMPA2 ABCC9 RRAD ADGRG6 IGFBP7 ADAMTS9 ADAMTS14	5.38e-06	189	159	7	d7ed96add29f219183c802895fbff519b627f635
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	CNTNAP3B STAB2 CNTNAP3 PARD6G THSD1 IGFBP7 ADAMTS9	5.57e-06	190	159	7	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 SPEG ABCC9 CRACD MRC2 ACAN NEURL1B	5.57e-06	190	159	7	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 ABCC9 ADH1B CRACD MRC2 ROBO1 NEURL1B	5.76e-06	191	159	7	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	COVID-19-kidney-vSMC/Pericyte\|kidney / Disease (COVID-19 only), tissue and cell type	SPEG ABCC9 ARTN THBS1 ADAMTS9 ACAN NEURL1B	5.76e-06	191	159	7	fad8eaa536001b911d05ae2b12150c2398cc6f88
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 SPEG SOSTDC1 GRIA1 RRAD ADGRG6 ADAMTSL4	5.76e-06	191	159	7	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 ABCC9 ADH1B CRACD MRC2 ROBO1 NEURL1B	5.76e-06	191	159	7	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDLIM7 SPEG SOSTDC1 ABCC9 GRIA3 RRAD ADGRG6	5.96e-06	192	159	7	992d08092edbc68c47b945deb8708379738c239a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 ABCC9 ADH1B CRACD THBS1 MRC2 NEURL1B	6.38e-06	194	159	7	240d122dcb9dd1ab2867503ad85869853adcacae
ToppCell	IPF-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	IMPA2 RCSD1 RRAD ADGRG6 IGFBP7 ADAMTS9 NEURL1B	6.38e-06	194	159	7	3892b188f424ffb80f3c75a1b6709a21c1e1601d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 ABCC9 ADH1B CRACD MRC2 ROBO1 NEURL1B	6.38e-06	194	159	7	cf0244a29934e515446ac917d3c30672b460fb04
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 ABCC9 ADH1B CRACD THBS1 MRC2 NEURL1B	6.38e-06	194	159	7	ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 ABCC9 ADH1B CRACD MRC2 ROBO1 NEURL1B	6.38e-06	194	159	7	ba7f971fb9a19423602da60770f23d9fead4a451
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 ABCC9 ADH1B THBS1 IGFBP7 MRC2 NEURL1B	6.60e-06	195	159	7	cad6563cc51d212554152c727fc2c249c6a07e4d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 ABCC9 ADH1B THBS1 IGFBP7 MRC2 NEURL1B	6.60e-06	195	159	7	783bfa8110161cbd6def50ce849cae676c39c458
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 ABCC9 ADH1B CRACD THBS1 MRC2 NEURL1B	6.60e-06	195	159	7	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCC9 RCSD1 FJX1 ARTN RRAD IGFBP7 ADAMTS9	6.60e-06	195	159	7	9b3fa1d42ec5aa2911f27a99cd8b57714c6bd604
ToppCell	(3)_Chondrocytes-(34)_Chondro-progen\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	MYOC GRIA1 CRACD THBS1 AOPEP ACAN CHST12	6.60e-06	195	159	7	d00cb2fab25f2026a9668a7f0686938a2e7155e2
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CNTNAP3B CNTNAP3 FJX1 ADGRG6 IGFBP7 ADAMTS9 NEURL1B	6.82e-06	196	159	7	5609b2d93172a488b35d854298a3a4e504e17e28
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 ESR1 ABCC9 ADH1B THBS1 IGFBP7 MRC2	6.82e-06	196	159	7	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	STAB2 CNTNAP3 ABCC9 PLXND1 ADGRG6 IGFBP7 ADAMTS9	7.05e-06	197	159	7	4e58bbf3ecb30b4c8199adcc04d2eb134d90de56
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 ABCC9 ADH1B CRACD IGFBP7 MRC2 NEURL1B	7.05e-06	197	159	7	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 ABCC9 ADH1B CRACD IGFBP7 MRC2 NEURL1B	7.05e-06	197	159	7	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	ASK428-Endothelial\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	STAB2 HRCT1 PARD6G THSD1 THBS1 IGFBP7 ADAMTS9	7.29e-06	198	159	7	d69d0ff115298596173a4278897a65007a71f5df
ToppCell	368C-Endothelial_cells\|368C / Donor, Lineage, Cell class and subclass (all cells)	CNTNAP3B ADGRG6 HEG1 IGFBP7 ADAMTS9 NEURL1B GARRE1	7.29e-06	198	159	7	9a2c2201baee51581733e183065298a97eba4553
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3B STAB2 HRCT1 PARD6G THSD1 SSPOP P3H2	7.29e-06	198	159	7	306e28d31fd587409a12dcccc6b2abd7dc9c2e0a
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3B STAB2 HRCT1 PARD6G THSD1 SSPOP P3H2	7.29e-06	198	159	7	05429f18e1d74880c1835568c86177f661b3477a
ToppCell	distal-mesenchymal-Vascular_Smooth_Muscle-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PDLIM7 ABCC9 RRAD ADH1B IGFBP7 ARVCF AOPEP	7.29e-06	198	159	7	5080767ff55326b7d94fca27d398237c4a15c1ed
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	STAB2 CNTNAP3 ABCC9 PLXND1 ADGRG6 IGFBP7 ADAMTS9	7.53e-06	199	159	7	ef7f7f7c861827574b120f48cf4052c563929081
ToppCell	10x3'2.3-week_14-16-Endothelial\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	STAB2 CNTNAP3 ABCC9 PLXND1 ADGRG6 IGFBP7 ADAMTS9	7.53e-06	199	159	7	41f046646fff65b7e51b63d3204f76ef32054781
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CNTNAP3B FJX1 ADGRG6 HEG1 IGFBP7 ADAMTS9 NEURL1B	7.53e-06	199	159	7	53b6a661d381b1ed3ea96e61e8bd1750de7d9fda
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PDLIM7 SPEG RRAD THBS1 IGFBP7 ARVCF AOPEP	7.53e-06	199	159	7	9a08c25bb4851ad4ac9db8916422280f71378c2c
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Bronchial_vessel\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CNTNAP3B FJX1 ADGRG6 HEG1 IGFBP7 ADAMTS9 NEURL1B	7.53e-06	199	159	7	9c753043024871b1f1436fc39defac4da85e10cd
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STAB2 PLXND1 THSD1 HEG1 IGFBP7 ADAMTS9 GARRE1	7.53e-06	199	159	7	f0bf75bfae7b288ecb6801be458b03ebd0108ea7
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CNTNAP3B FJX1 ADGRG6 HEG1 IGFBP7 ADAMTS9 NEURL1B	7.53e-06	199	159	7	d017dd91f9b10038f1f83753a766e534da2dbe89
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PDLIM7 SPEG RRAD THBS1 IGFBP7 ARVCF AOPEP	7.53e-06	199	159	7	2ed10c5e15c9d5ed0a8bea580842348d5698a07b
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_lymphatic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3B STAB2 HRCT1 PARD6G THSD1 ADAMTS9 P3H2	7.78e-06	200	159	7	b515b2ab0c3f5928dd67f2f227fc932451c272bb
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3B STAB2 HRCT1 PARD6G THSD1 ADAMTS9 P3H2	7.78e-06	200	159	7	35f6c7f2469d12748c27f2a5d4a161ef839b4a07
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	SOSTDC1 GRIA3 ADGRG6 THBS1 MRC2 ROBO1 RIMS1	7.78e-06	200	159	7	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SH3TC2 ESR1 SOSTDC1 NBEA AP3B2 C1QB	1.54e-05	148	159	6	5983c4546f527a0b599cfcbd8a6cb937a1d6f895
ToppCell	Fetal_29-31_weeks-Mesenchymal-chondrocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SH3TC2 MYOC THBS1 TRMT44 MRC2 DMBT1	1.86e-05	153	159	6	65641cc82883716dba0fefb749a30174a63f4da5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PARD6G ABCC9 ARTN RRAD ADGRG6 IGFBP7	2.08e-05	156	159	6	6365b69ede98bc866e996bc52736b00401aacf6f
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122\|Adult / Lineage, Cell type, age group and donor	IMPA2 ANK3 MAGI3 MBIP CFB NECAB3	2.16e-05	157	159	6	31d1bd9138c60e8485664ec4144f987226e3eef9
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDLIM7 SPEG ARTN RRAD IGFBP7 ACAN	2.66e-05	163	159	6	51dee6c21cbeca4e17d1cc386e203f0c403089e8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B NLRP1 RCSD1 PLXND1 CDCA7 NEURL1B	2.85e-05	165	159	6	6a621b300442c52adfc15b61d3a6d3a3cb00099f
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCC9 RCSD1 RRAD GFRA3 ADGRG6 P3H2	3.37e-05	170	159	6	1f994b690e881106a5d54b3080ccce6260bc3ac5
ToppCell	droplet-Fat-SCAT-30m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP3 MYOC HRCT1 SSUH2 IGFBP7 TREML1	3.72e-05	173	159	6	eb58b0189e71e38d4f4f1cf544a82cde8d1c86bc
ToppCell	3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CNTNAP3 ADGRG6 HEG1 IGFBP7 ADAMTS9 GARRE1	3.72e-05	173	159	6	b57d14e2c2368304cb903562d06ce8228f53857c
ToppCell	15-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	RTN4R PARD6G HEG1 ACAN ROBO1 NEURL1B	3.84e-05	174	159	6	fa0681e91724b9a51ee28b214ea5aa14e62ba1a3
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCC9 ARTN IGFBP7 ADAMTS9 ACAN NEURL1B	3.84e-05	174	159	6	015d3742d3d79a57413a333f00ef2d380a9848dd
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 CRACD HEG1 CDCA7 GPR149	4.09e-05	176	159	6	95d5a4fdff1b9c715636684d22e06f8727ac0e7a
ToppCell	droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPOR HRCT1 FJX1 RRAD SSPOP NEURL1B	4.09e-05	176	159	6	f931192e3cc65414e2245354f443473696cc7ce8
ToppCell	3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SIN3B CNTNAP3 PARD6G CALHM6 PLXND1 IGFBP7	4.09e-05	176	159	6	5d3b2395bb842eea39175f5af6a4c76527e2fc31
ToppCell	droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPOR HRCT1 FJX1 RRAD SSPOP NEURL1B	4.09e-05	176	159	6	e2b59a904c5c8f9c88e1e63788e9b6485f22edd0
ToppCell	Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Lmcd1_(Mural.Rgs5Acta2.Lmcd1)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ABCC9 RRAD CFB M1AP ADAMTS14	4.11e-05	107	159	5	2f84089acc794b43ee59452dc8f90ca7261ebd41
ToppCell	Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Lmcd1_(Mural.Rgs5Acta2.Lmcd1)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ABCC9 RRAD CFB M1AP ADAMTS14	4.11e-05	107	159	5	0b45241cc52d10225966b49941efb66997184158
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 CNTNAP3 LDHAL6B PARD6G GRIA1 THSD1	4.22e-05	177	159	6	c8a51e480b978dc0ded85583261f2c892e085be8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 CNTNAP3 LDHAL6B PARD6G GRIA1 THSD1	4.22e-05	177	159	6	c274fbdc141855ff4581d437d4997c64cc193278
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 CNTNAP3 LDHAL6B PARD6G GRIA1 THSD1	4.22e-05	177	159	6	f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231\|Adult / Lineage, Cell type, age group and donor	CNTNAP3B STAB2 PARD6G THSD1 IGFBP7 ADAMTS9	4.36e-05	178	159	6	c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCell	Striatum-Endothelial-MURAL\|Striatum / BrainAtlas - Mouse McCarroll V32	HRCT1 ABCC9 RCSD1 RRAD IGFBP7 P3H2	4.50e-05	179	159	6	3d58babf44e47462c3d4129dd2e94a2339fd7ce0
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 CRACD HEG1 CDCA7 GPR149	4.50e-05	179	159	6	3b0f8781232e1d42b6f8913bc989a14b3f978e79
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MPP3 IMPA2 ANK3 MBIP P3H2 SEC61B	4.50e-05	179	159	6	7db6b97a1c4c7a163d5da4351ba36ac1785d9d7b
ToppCell	Striatum-Endothelial-MURAL-M1(Rgs5Acta2)\|Striatum / BrainAtlas - Mouse McCarroll V32	HRCT1 ABCC9 RCSD1 RRAD IGFBP7 P3H2	4.50e-05	179	159	6	99167ac678cae5c35b1d4f4a81b32000437c00c2
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI3 NBEA MESP1 CELSR1 TMEM132D RIMS1	4.64e-05	180	159	6	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	ANK3 MAGI3 ABCC9 MBIP P3H2 DMBT1	4.64e-05	180	159	6	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP3 SH3TC2 STAB2 PLXND1 THSD1 IGFBP7	4.78e-05	181	159	6	a53f05c4c47465ee62e353716456bd09ab464b23
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPTLC2 EVC CELSR1 TMEM132D P3H2 MRC2	4.78e-05	181	159	6	071f9bb5d39070cdc473d9b0e094d196bc702b56
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 CDCA7 P3H2 GPR149 ROBO1	4.93e-05	182	159	6	d4cb23b5a974c096a0ce84b47fe351eef44894d7
ToppCell	10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-LMPP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PPAN RTN4R RHPN1 MIDN IL17RE CHST12	4.93e-05	182	159	6	69b5cae6fe3bbb0fc60bd2f71b6cfa6cbb0b00ee
ToppCell	Basal\|World / shred by cell class for mouse tongue	SOSTDC1 CELSR1 HEG1 IGFBP7 AOPEP P3H2	5.08e-05	183	159	6	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	MPP3 MAGI3 CDKL5 HEG1 IL17RE P3H2	5.08e-05	183	159	6	6821dca076318115d360ff426eb1218cfe104063
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 SOSTDC1 GRIA3 GFRA3 P3H2 TREML1	5.08e-05	183	159	6	876b4f128c2168fdae7488201ff44f19c06c8415
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 SOSTDC1 GRIA3 GFRA3 P3H2 TREML1	5.08e-05	183	159	6	b190b650e61b1b20baf5e42d04acac82d3fd1400
ToppCell	5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STAB2 CNTNAP3 PARD6G THSD1 IGFBP7 ADAMTS9	5.08e-05	183	159	6	2d0d3b486498a7903fa9a1f48b189291da49c430
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MPP3 IMPA2 ANK3 MBIP CELSR1 P3H2	5.24e-05	184	159	6	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-myocytic\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDLIM7 CNTNAP3 SOSTDC1 RRAD KLHL31 AOPEP	5.24e-05	184	159	6	5cfc19ffb9f074bdf0d81c86e212a708ec141631
Drug	Tolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	EPOR SP1 TBC1D5 ESR1 ARTN THSD1 PAOX CD6 ARVCF IGHMBP2	1.12e-06	195	158	10	4167_DN
Drug	Zoxazolamine [61-80-3]; Down 200; 23.8uM; MCF7; HT_HG-U133A	EPOR SPTLC2 ESR1 HGSNAT NKX3-2 ARTN TRIM14 ARNT ARVCF AGFG2	1.29e-06	198	158	10	2625_DN
Drug	Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A	SP1 SPTLC2 MYOC NLRP1 CLIP4 TAF6L ARNT MRC2 SMG6	8.49e-06	193	158	9	3845_UP
Drug	Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A	SP1 ESR1 ARTN TRIM14 WAC TAF6L GRK2 ARVCF NFX1	8.85e-06	194	158	9	2295_DN
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	EPOR PDLIM7 SPTLC2 TBC1D5 ESR1 CLIP4 TAF6L CD6 IGHMBP2	9.22e-06	195	158	9	2290_DN
Drug	raloxifene hydrochloride; Down 200; 0.1uM; MCF7; HG-U133A	STAB2 ESR1 ARTN PLXND1 THBS1 ARNT CD6 ACAN NFX1	1.04e-05	198	158	9	202_DN
Drug	Condelphine [7633-69-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	EPOR STAB2 SPTLC2 ESR1 NLRP1 PAOX TAF6L ARVCF PHLPP2	1.09e-05	199	158	9	6357_UP
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; MCF7; HT_HG-U133A	MPP3 EPOR SIN3B PDLIM7 SPTLC2 ARTN TRIM14 IGHMBP2 CHST12	1.09e-05	199	158	9	1703_DN
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A	EPOR PDLIM7 ESR1 ARTN PAOX THBS1 GTPBP2 GARRE1 PHLPP2	1.09e-05	199	158	9	2214_DN
Drug	Gdrgdsp	RTN4R GRIA1 THSD1 SHKBP1 THBS1 ACAN ADAMTSL4	1.12e-05	109	158	7	CID000115346
Drug	Benzoates	ESR1 GRIA1 GRIA3	3.80e-05	10	158	3	ctd:D001565
Drug	5-fluorowillardiine	GRIA1 GRIA3	4.79e-05	2	158	2	ctd:C095178
Drug	Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	SP1 STAB2 ESR1 ACOT7 TAF6L ARNT GRK2 SYNJ1	6.51e-05	194	158	8	4176_DN
Drug	Betamethasone [378-44-9]; Up 200; 10.2uM; MCF7; HT_HG-U133A	EPOR GPR25 PDLIM7 SPTLC2 HEG1 GRK2 SYNJ1 NFX1	6.51e-05	194	158	8	5328_UP
Drug	Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	GPR25 NRL ESR1 ABCC9 ADAMTS13 ARVCF ACAN DMBT1	6.75e-05	195	158	8	3747_UP
Drug	Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; HL60; HT_HG-U133A	CENPB MYOC ESR1 GRIA3 HEG1 CD6 ACAN ZNF415	6.75e-05	195	158	8	2736_UP
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	STAB2 PDLIM7 SPTLC2 NKX3-2 THSD1 TRIM14 ARVCF PHLPP2	6.75e-05	195	158	8	2241_DN
Drug	AC1NX069	THSD1 THBS1 CD6 ADAMTSL4	6.90e-05	32	158	4	CID005716906
Drug	rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A	EPOR SP1 ANK3 PDLIM7 ESR1 THBS1 GRK2 NFX1	6.99e-05	196	158	8	5975_UP
Drug	Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; MCF7; HT_HG-U133A	SP1 SPTLC2 TBC1D5 ESR1 PLXND1 THSD1 HEG1 ROBO1	6.99e-05	196	158	8	5249_DN
Drug	Pyrithyldione [77-04-3]; Down 200; 24uM; MCF7; HT_HG-U133A	EPOR ESR1 ARTN PAOX ARNT NECAB3 STX16 GARRE1	6.99e-05	196	158	8	3482_DN
Drug	Cefazolin sodium salt [27164-46-1]; Down 200; 8.4uM; PC3; HT_HG-U133A	PDLIM7 ESR1 NLRP1 ARTN PLXND1 HEG1 NFX1 ZNF415	6.99e-05	196	158	8	3686_DN
Drug	Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; PC3; HT_HG-U133A	EPOR ANK3 TBC1D5 AGFG2 NECAB3 STX16 ZNF415 PRRC2B	6.99e-05	196	158	8	7147_DN
Drug	Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A	EPOR ESR1 PAOX THBS1 ARNT GRK2 ARVCF DCAF17	7.25e-05	197	158	8	6519_DN
Drug	Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A	SP1 GPR25 SPTLC2 TAF6L ACAN NFX1 RIMS1 STX16	7.25e-05	197	158	8	5482_UP
Drug	Epirizole [18694-40-1]; Up 200; 17uM; PC3; HT_HG-U133A	PDLIM7 SPEG ESR1 PLXND1 THSD1 TRIM14 CLIP4 GRK2	7.25e-05	197	158	8	7292_UP
Drug	Panthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A	EPOR SIN3B ESR1 HGSNAT UPF3A ARTN GTPBP2 NFX1	7.25e-05	197	158	8	1680_DN
Drug	0173570-0000 [211245-44-2]; Up 200; 1uM; MCF7; HT_HG-U133A	NRL SPTLC2 TBC1D5 ESR1 PAOX TAF6L THBS1 AGFG2	7.25e-05	197	158	8	4715_UP
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A	PDLIM7 ADAMTS13 TAF6L HEG1 IGFBP7 ACAN IGHMBP2 C1QB	7.25e-05	197	158	8	4727_UP
Drug	deferoxamine mesylate salt; Down 200; 100uM; PC3; HG-U133A	SH3TC2 FJX1 SSUH2 THBS1 ADO ACAN ROBO1 DHX29	7.25e-05	197	158	8	460_DN
Drug	Pridinol methanesulfonate salt [6856-31-1]; Up 200; 10.2uM; PC3; HT_HG-U133A	SOSTDC1 ADAMTS13 ARNT GRK2 ARVCF IGHMBP2 NFX1 DMBT1	7.25e-05	197	158	8	5860_UP
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A	SP1 ESR1 HGSNAT ACOT7 THSD1 TRIM14 ARVCF NFX1	7.51e-05	198	158	8	2297_DN
Drug	PNU-0251126 [267429-19-6]; Up 200; 1uM; PC3; HT_HG-U133A	SP1 NKX3-2 NLRP1 TRIM14 TAF6L ARNT GRK2 IGHMBP2	7.51e-05	198	158	8	7390_UP
Drug	Oxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HT_HG-U133A	ESR1 NLRP1 ADAMTS13 PLXND1 TRIM14 ARNT SYNJ1 DMBT1	7.51e-05	198	158	8	4246_UP
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A	EPOR PDLIM7 ARTN THSD1 TRIM14 PAOX ARNT HEG1	7.51e-05	198	158	8	5684_DN
Drug	Isocarboxazid [59-63-2]; Up 200; 17.2uM; PC3; HT_HG-U133A	SP1 SH3TC2 PDLIM7 ABCC9 ARTN TAF6L IGHMBP2 ADAMTSL4	7.51e-05	198	158	8	7383_UP
Drug	GSK-3 Inhibitor IX; Down 200; 0.5uM; MCF7; HT_HG-U133A	SPTLC2 ESR1 ACOT7 DHX30 TAF6L GTPBP2 ARNT ARVCF	7.51e-05	198	158	8	6589_DN
Drug	Cytisine (-) [485-35-8]; Up 200; 21uM; HL60; HG-U133A	MRS2 PDLIM7 ACOT7 ARTN THSD1 TRIM14 ADO ACAN	7.78e-05	199	158	8	1766_UP
Drug	Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; HL60; HT_HG-U133A	EPOR PDLIM7 NLRP1 HEG1 SYNJ1 AGFG2 NECAB3 RIMS1	7.78e-05	199	158	8	1277_UP
Drug	retinoic acid; Up 200; 1uM; PC3; HG-U133A	EPOR STAB2 MYOC ARVCF ACAN IGHMBP2 NFX1 PRRC2B	7.78e-05	199	158	8	447_UP
Drug	Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; HL60; HT_HG-U133A	ANK3 PDLIM7 ESR1 GRIA3 NLRP1 PAOX ARNT SYNJ1	7.78e-05	199	158	8	3017_DN
Drug	Torsemide [56211-40-6]; Up 200; 11.4uM; HL60; HT_HG-U133A	PDLIM7 TBC1D5 ESR1 NLRP1 THBS1 CELSR1 ARVCF AGFG2	7.78e-05	199	158	8	2956_UP
Drug	clozapine; Up 200; 10uM; MCF7; HG-U133A	EPOR PDLIM7 SPEG UPF3A TRIM14 TAF6L ARNT ARVCF	7.78e-05	199	158	8	416_UP
Drug	CPENSpm	ESR1 PAOX	1.43e-04	3	158	2	CID000127816
Drug	5-aza-2'-deoxycytidine	MPP3 SP1 CENPB ESR1 GRIA1 ADH1B THBS1 IGFBP7 TMEM132D AP3B2 ELANE ROBO1 DMBT1 SMG6	1.50e-04	638	158	14	CID000016886
Drug	8-chloroadenosine	SP1 ADO GRK2 TMEM132D	1.68e-04	40	158	4	CID000147569
Drug	N-(aminomethyl)succinamic acid	CENPB INSRR UPF3A SMG6	1.68e-04	40	158	4	CID000465394
Drug	trichostatin A ; Up 200; 1uM; MCF7; HT_HG-U133A_EA	EPOR SPTLC2 NLRP1 THSD1 AGFG2 CHST12 GARRE1	2.51e-04	178	158	7	873_UP
Drug	TFE-NAC	NLRP1 ELANE	2.85e-04	4	158	2	CID000164093
Drug	3-pyridazinol 1-oxide	GRIA1 GRIA3	2.85e-04	4	158	2	CID000574311
Drug	MMTP	INSRR ELANE	2.85e-04	4	158	2	CID000018391
Drug	1i32	ACOT7 GRIA3 TSC2 UPF3A IGHMBP2 SMG6	2.86e-04	129	158	6	CID000446186
Drug	NPC 15437	UTS2R GRIA1 NLRP1 GRK2	2.90e-04	46	158	4	CID000004548
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	ESR1 ARTN THSD1 TRIM14 THBS1 HEG1 NFX1	3.17e-04	185	158	7	5235_DN
Drug	Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; MCF7; HT_HG-U133A	SP1 ESR1 FJX1 ARTN TRIM14 THBS1 AOPEP	3.17e-04	185	158	7	4688_DN
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	EPOR NLRP1 NBEA THSD1 SYNJ1 AGFG2 GARRE1	3.17e-04	185	158	7	6916_UP
Drug	2-deoxy-D-glucose; Up 200; 10000uM; MCF7; HG-U133A	STAB2 SPTLC2 SSUH2 THBS1 CD6 GRK2 ARVCF	3.28e-04	186	158	7	344_UP
Drug	ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A	TBC1D5 ESR1 FJX1 ARTN THBS1 ARNT GRK2	3.39e-04	187	158	7	6872_DN
Drug	Lovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A	MPP3 PDLIM7 ESR1 ARTN THSD1 THBS1 ARVCF	3.50e-04	188	158	7	2854_UP
Drug	Phenacetin [62-44-2]; Up 200; 22.4uM; MCF7; HT_HG-U133A	MPP3 SP1 STAB2 SPTLC2 ESR1 ACAN IGHMBP2	3.61e-04	189	158	7	2832_UP
Drug	Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A	PDLIM7 SPTLC2 TBC1D5 ESR1 ARTN TRIM14 HEG1	3.73e-04	190	158	7	4114_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	PDLIM7 ARTN DHX30 PAOX ARNT GRK2 NFX1	3.85e-04	191	158	7	5581_DN
Drug	Colchicine [64-86-8]; Up 200; 10uM; PC3; HT_HG-U133A	MPP3 ESR1 NKX3-2 ABCC9 ARTN TRIM14 TAF6L	3.85e-04	191	158	7	4614_UP
Drug	CP-319743 [172078-87-4]; Up 200; 10uM; MCF7; HT_HG-U133A	EPOR SPEG TBC1D5 ESR1 GRIA3 ARNT CD6	3.85e-04	191	158	7	7486_UP
Drug	Thiostrepton [1393-48-2]; Down 200; 2.4uM; PC3; HT_HG-U133A	EPOR CENPB TBC1D5 EVC FJX1 ADGRG6 THBS1	3.85e-04	191	158	7	4563_DN
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A	SIN3B ESR1 ACOT7 FJX1 ARTN PLXND1 DCAF17	3.85e-04	191	158	7	6987_DN
Drug	Proglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A	SPEG ESR1 CLIP4 MRC2 AGFG2 STX16 PHLPP2	3.85e-04	191	158	7	3861_UP
Drug	Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; MCF7; HT_HG-U133A	EPOR TBC1D5 ESR1 ARTN ARNT HEG1 GARRE1	4.09e-04	193	158	7	4146_DN
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; PC3; HT_HG-U133A	NRL PDLIM7 MYOC CD6 GRK2 MRC2 DMBT1	4.09e-04	193	158	7	4676_UP
Drug	Thiamphenicol [15318-45-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A	EPOR TBC1D5 ESR1 HGSNAT ARNT GRK2 ROBO1	4.09e-04	193	158	7	7033_DN
Drug	Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	SH3TC2 SPTLC2 ARTN THBS1 HEG1 GRK2 DMBT1	4.09e-04	193	158	7	2079_UP
Drug	Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; PC3; HT_HG-U133A	SH3TC2 STAB2 SPTLC2 ESR1 ARTN THBS1 CD6	4.09e-04	193	158	7	7385_UP
Drug	Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	SPTLC2 CELSR1 CD6 GRK2 ARVCF IGHMBP2 DMBT1	4.22e-04	194	158	7	7379_UP
Drug	splitomicin; Up 200; 20uM; PC3; HG-U133A	EPOR SPEG NBEA TSC2 ARNT ARVCF ACAN	4.22e-04	194	158	7	661_UP
Drug	Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; HL60; HT_HG-U133A	ANK3 SPTLC2 MYOC ADAMTS13 ARVCF ACAN IGHMBP2	4.22e-04	194	158	7	3100_UP
Drug	Zardaverine [101975-10-4]; Up 200; 15uM; MCF7; HT_HG-U133A	EPOR PDLIM7 SPTLC2 ESR1 ARNT ARVCF ACAN	4.22e-04	194	158	7	7347_UP
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	PDLIM7 SPTLC2 ESR1 ARTN PLXND1 ADGRG6 THBS1	4.22e-04	194	158	7	7446_DN
Drug	Nitrofural [59-87-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A	SP1 STAB2 ANK3 SPTLC2 TRIM14 TAF6L GRK2	4.36e-04	195	158	7	3320_DN
Drug	diclofenac sodium; Down 200; 10uM; MCF7; HG-U133A	ANK3 PDLIM7 ESR1 ARNT ARVCF MRC2 ACAN	4.36e-04	195	158	7	333_DN
Drug	2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A	EPOR ANK3 ESR1 SOSTDC1 ARTN HEG1 STX16	4.36e-04	195	158	7	1214_UP
Drug	semustine; Down 200; 100uM; MCF7; HT_HG-U133A	EPOR ESR1 NKX3-2 ARTN TRIM14 MRC2 IGHMBP2	4.36e-04	195	158	7	7540_DN
Drug	Salsolinol hydrobromide [38221-21-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A	EPOR ANK3 PDLIM7 ESR1 THSD1 ARNT GRK2	4.36e-04	195	158	7	2791_DN
Drug	Disopyramide [3737-09-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PDLIM7 ACOT7 MBIP TAF6L ARNT NFX1 STX16	4.36e-04	195	158	7	7035_DN
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; HL60; HT_HG-U133A	EPOR PLXND1 MBIP ARNT CD6 GRK2 PHLPP2	4.36e-04	195	158	7	2355_DN
Drug	Bisoprolol fumarate; Up 200; 9uM; MCF7; HT_HG-U133A	EPOR ANK3 PDLIM7 SPTLC2 ESR1 ARTN GARRE1	4.36e-04	195	158	7	5348_UP
Drug	Sulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A	SP1 TBC1D5 ESR1 NKX3-2 ARTN TRIM14 ARVCF	4.36e-04	195	158	7	4740_DN
Drug	Risperidone [106266-06-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	EPOR SP1 PDLIM7 ESR1 NKX3-2 THBS1 GTPBP2	4.36e-04	195	158	7	3508_DN
Drug	Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A	MYOC SPEG ADH1B THBS1 P3H2 ACAN CXCR1	4.36e-04	195	158	7	6415_UP
Drug	Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; PC3; HT_HG-U133A	EPOR SPTLC2 TBC1D5 TRIM14 THBS1 P3H2 NFX1	4.36e-04	195	158	7	4646_DN
Drug	Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A	NRL ADAMTS13 ARTN TAF6L ARVCF NFX1 DMBT1	4.36e-04	195	158	7	2897_UP
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A	SP1 PDLIM7 ESR1 ARTN PAOX CD6 NFX1	4.36e-04	195	158	7	4117_DN
Drug	Etofenamate [30544-47-9]; Up 200; 10.8uM; HL60; HT_HG-U133A	ANK3 PDLIM7 SPTLC2 SPEG NLRP1 NBEA THBS1	4.36e-04	195	158	7	2907_UP
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	SPTLC2 ESR1 ARTN THSD1 TRIM14 CD6 ARVCF	4.36e-04	195	158	7	4180_DN
Drug	Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A	SP1 ESR1 ARTN PAOX ARNT MRC2 ACAN	4.49e-04	196	158	7	5757_UP
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; HL60; HG-U133A	EPOR ANK3 MYOC MBIP THBS1 ARVCF GARRE1	4.49e-04	196	158	7	1445_UP
Drug	Flurandrenolide [1524-88-5]; Up 200; 9.2uM; PC3; HT_HG-U133A	SP1 STAB2 ARTN ADGRG6 THBS1 CD6 DMBT1	4.49e-04	196	158	7	7378_UP
Drug	Acyclovir [59277-89-3]; Up 200; 17.8uM; PC3; HT_HG-U133A	SPTLC2 SOSTDC1 GRK2 IGFBP7 MRC2 NFX1 AGFG2	4.49e-04	196	158	7	4683_UP
Drug	Nystatine [1400-61-9]; Up 200; 4.4uM; MCF7; HT_HG-U133A	STAB2 ESR1 ARTN GRK2 ARVCF NFX1 SMG6	4.49e-04	196	158	7	4807_UP
Drug	Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A	SP1 SPTLC2 THBS1 ARNT GRK2 DCAF17 AGFG2	4.49e-04	196	158	7	7425_UP
Drug	Ribavirin [36791-04-5]; Up 200; 16.4uM; PC3; HT_HG-U133A	PDLIM7 NLRP1 ARTN PLXND1 THSD1 CLIP4 TAF6L	4.49e-04	196	158	7	7316_UP
Disease	autism spectrum disorder (implicated_via_orthology)	CNTNAP3B CNTNAP3 NBEA TSC2 WDR75 ARVCF RIMS1	1.72e-05	152	156	7	DOID:0060041 (implicated_via_orthology)
Disease	idiopathic scoliosis (implicated_via_orthology)	SSPOP KIF7 ADGRG6	7.72e-05	16	156	3	DOID:0060250 (implicated_via_orthology)
Disease	polycythemia vera (is_marker_for)	EPOR ELANE	2.75e-04	5	156	2	DOID:8997 (is_marker_for)
Disease	scoliosis (implicated_via_orthology)	SSPOP ADAMTS9	2.75e-04	5	156	2	DOID:0060249 (implicated_via_orthology)
Disease	scoliosis	ADGRG6 RSPO1	4.11e-04	6	156	2	EFO_0004273
Disease	Fibroid Tumor	ESR1 TSC2	4.11e-04	6	156	2	C0023267
Disease	Psychosexual Disorders	GRIA1 GRIA3	4.11e-04	6	156	2	C0033953
Disease	Hypoactive Sexual Desire Disorder	GRIA1 GRIA3	4.11e-04	6	156	2	C0020594
Disease	Sexual Arousal Disorder	GRIA1 GRIA3	4.11e-04	6	156	2	C0036902
Disease	Frigidity	GRIA1 GRIA3	4.11e-04	6	156	2	C0016722
Disease	Orgasmic Disorder	GRIA1 GRIA3	4.11e-04	6	156	2	C0029261
Disease	Uterine Fibroids	ESR1 TSC2	5.73e-04	7	156	2	C0042133
Disease	hereditary lymphedema (is_implicated_in)	THSD1 CELSR1	5.73e-04	7	156	2	DOID:0050580 (is_implicated_in)
Disease	Disproportionate short stature	NKX3-2 EVC SLC39A13 ACAN	7.54e-04	77	156	4	C0878659
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP3B CNTNAP3	7.62e-04	8	156	2	DOID:0060308 (implicated_via_orthology)
Disease	Febrile Convulsions	IMPA2 PIGH	9.76e-04	9	156	2	C0009952
Disease	Bone Diseases	ESR1 SLC39A13	1.22e-03	10	156	2	C0005940
Disease	disseminated intravascular coagulation (is_marker_for)	ADAMTS13 ELANE	1.22e-03	10	156	2	DOID:11247 (is_marker_for)
Disease	membranoproliferative glomerulonephritis (biomarker_via_orthology)	MYOC CXCR1	1.22e-03	10	156	2	DOID:2920 (biomarker_via_orthology)
Disease	Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement	ANK3 SHKBP1	1.48e-03	11	156	2	EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175
Disease	Neurodevelopmental Disorders	WAC DHX30 CDKL5 RIMS1	1.52e-03	93	156	4	C1535926
Disease	Malignant neoplasm of breast	EPOR UTS2R PDLIM7 ESR1 LDHAL6B ARTN RRAD THBS1 IGFBP7 P3H2 C1QB ROBO1 BOD1L1 TREML1	1.74e-03	1074	156	14	C0006142
Disease	pleurisy (implicated_via_orthology)	ESR1 ELANE	2.08e-03	13	156	2	DOID:10247 (implicated_via_orthology)
Disease	Schizophrenia	SP1 IMPA2 ANK3 ESR1 RTN4R GRIA1 GRIA3 GFRA3 THBS1 ARVCF NCAN C1QB	2.64e-03	883	156	12	C0036341
Disease	hepatic encephalopathy (biomarker_via_orthology)	EPOR GRIA1	2.79e-03	15	156	2	DOID:13413 (biomarker_via_orthology)
Disease	pulse pressure measurement	ESR1 ABCC9 NBEA UPF3A SSPOP CFB ADH1B ADO KANSL1 ARVCF CDCA7 MRC2 NEURL1B GARRE1 SMG6 PTCD3	2.95e-03	1392	156	16	EFO_0005763
Disease	central nervous system disease (implicated_via_orthology)	GRIA1 GRIA3	3.17e-03	16	156	2	DOID:331 (implicated_via_orthology)
Disease	ocular hypertension (biomarker_via_orthology)	MYOC C1QB	3.59e-03	17	156	2	DOID:9282 (biomarker_via_orthology)
Disease	peripheral arterial disease, traffic air pollution measurement	IMPA2 ESR1 NBEA ADGRG6 RIMS1	3.78e-03	194	156	5	EFO_0004265, EFO_0007908
Disease	autoimmune thyroid disease, type 1 diabetes mellitus	MAGI3 CFB	4.02e-03	18	156	2	EFO_0006812, MONDO_0005147
Disease	body fat distribution	ESR1 ADGRG6 ACAN ADAMTS14 TSGA10IP	4.49e-03	202	156	5	EFO_0004341
Disease	neuroimaging measurement	VWA5B2 SP1 ANK3 TBC1D5 PLXND1 CFB THBS1 CELSR1 KANSL1 WDR75 SYNJ1 ROBO1 SMG6	4.56e-03	1069	156	13	EFO_0004346
Disease	transient cerebral ischemia (implicated_via_orthology)	ESR1 PLXND1 ELANE	4.77e-03	64	156	3	DOID:224 (implicated_via_orthology)
Disease	pantothenic acid mesurement	IGFBP7 TMEM132D	4.96e-03	20	156	2	EFO_0010519

Protein segments in the cluster

Peptide	Gene	Start	Entry
CEFGRQASSRRLVAG	ACOT7	11	O00154
RLSFVRNRCRNGLGS	ARNT	281	P27540
AGLTDNGCRRRRQDR	SMG6	271	Q86US8
RALGCFSRDAGVVQR	DCAF17	16	Q5H9S7
NGGSESLFRQCRRRL	CDRT15L2	16	A8MXV6
NGGRCREKRRGVTCD	CNTNAP3	971	Q9BZ76
SKRRLQDVAGRGCCR	CCDC187	401	A0A096LP49
LALARSRGARACSGD	C8orf82	11	Q6P1X6
RSNLGVGRSLRDCLS	C8orf86	16	Q6ZUL3
SQRRRRDDASCFGGK	ARVCF	606	O00192
SVRCGRGQRSRQVRC	ADAMTSL4	796	Q6UY14
QRIARQACLTFRGSG	ADO	11	Q96SZ5
RQQGRRRCRESFSPA	C9orf163	76	Q8N9P6
QICGRNGKRSNRTLR	ADGRG6	1046	Q86SQ4
RGTLQDGTRRFTCRG	ADH1B	121	P00325
NRRDGFCRKRRTGCS	DEPDC4	41	Q8N2C3
RNRSACRVLRAGQAA	GTPBP2	461	Q9BX10
DRSFRARALDGACGR	GPR25	311	O00155
GACGRTGRLARRISS	GPR25	321	O00155
TGRLNQTRAGRDCAR	APCDD1L	146	Q8NCL9
SRRFRRSQSDCGELG	RCSD1	171	Q6JBY9
THRLCARERGVRGTQ	LINC00528	26	Q8N1L1
CREAINRARLRDAGG	ARMC5	356	Q96C12
NLSGGQRQRICVARA	ABCC9	811	O60706
LQRERRAGAECGLAR	AOPEP	661	Q8N6M6
RAGAECGLARQVRAE	AOPEP	666	Q8N6M6
FIANNGTREGCAARR	CELSR1	1636	Q9NYQ6
LQRQGRAGRVRDGFC	DHX29	976	Q7Z478
VIQRRGRAGRCQSGF	DHX30	776	Q7L2E3
ANNSRCEGELRLGER	CLIP4	476	Q8N3C7
REPALSRAGSCRQRG	CGAS	111	Q8N884
SRAGSCRQRGARCST	CGAS	116	Q8N884
GLCARRRSQASLSAG	DANCR	71	P0C864
CSRSCGGGVVTRRRQ	ADAMTS13	396	Q76LX8
RSCGGGVRSRSRSCN	ADAMTS14	566	Q8WXS8
RDVNRRLGCLGRGAQ	GRK2	431	P25098
QAIGRCATNIGRVRD	AP3B2	431	Q13367
AREGRSARRAARGNL	RASSF5	56	Q8WWW0
NARRQAGTRRRESLG	RRAD	261	P55042
NGGSESLFRRCRRRL	CDRT15	16	Q96T59
TLRGSANRTCQVNGR	CFB	136	P00751
CSRGLTLRGSQRRTC	CFB	191	P00751
SDGRRARVTCAENRA	CD6	146	P30203
TGRRAGLCEQARSCR	PTCD3	21	Q96EY7
QNTLQSRRTRIRGGC	KLHL31	301	Q9H511
REGCFRSQGASLRLA	M1AP	101	Q8TC57
RAGSGQDQCRKSRGR	MAGI3	1271	Q5TCQ9
AQRQRSGSREQAGAR	JMY	51	Q8N9B5
RAAGARGCRLRSQLV	ARTN	116	Q5T4W7
GARQRRQSRLELCSR	IL17RE	641	Q8NFR9
QTRGRGRARGSKCFL	DDX58	726	O95786
VERNRTAAGGNRVRR	HRCT1	41	Q6UXD1
RQRVDVSRRGSAGDC	GRIA3	326	P42263
CRRRQQRRGPAETAA	FBXO31	16	Q5XUX0
GFCQLRRRGNISAVA	PLXND1	146	Q9Y4D7
NRRQGGRERLASTND	ESR1	156	P03372
RIIGSGCNLDTARFR	LDHAL6B	206	Q9BYZ2
AGCTQGSERRVLRQL	NLRP1	126	Q9C000
SVRELNRQLRGCGRD	NRL	141	P54845
RNRISNCSQRAGARP	KIF7	641	Q2M1P5
VAACGRRANLIGRSR	MRS2	36	Q9HD23
RRGQCPQTRDTARAV	MYOC	181	Q99972
NCGTQRRLDSNRIGR	NFX1	31	Q12986
AQERAARCTRRTSGS	KANSL1	1056	Q7Z3B3
ARQRCQRAGGAVLSI	MRC2	1291	Q9UBG0
VRLRRNASSAGRLQG	MEFV	201	O15553
RSVVASCQVGRLGQR	MSLNL	266	Q96KJ4
CQLLGSQRRIFRAGS	HEG1	1161	Q9ULI3
TARLRALDQADSGCR	MIEF1	346	Q9NQG6
CQLRAASQRAESRGE	IGFBP7	131	Q16270
CRTALSGQQDRRNDL	P3H2	561	Q8IVL5
RGRGAFCNGQRLRVS	IMPA2	146	O14732
RENDSRRECRRSVGQ	OOSP4A	126	A0A2R8YFL7
RACGERLSLGLSRAQ	PDLIM7	71	Q9NR12
AERGSLGAGSLCRRR	PARD6G	101	Q9BYG4
NECRRLGARLATTGQ	ACAN	271	P16112
RTDRCRRGFGVCTAQ	PATE3	31	B3GLJ2
ARCGGRVSLRSNNED	RIMS1	141	Q86UR5
AAAGAEACRRENRGT	GPR149	281	Q86SP6
LERGGCGRSSNRLAR	FJX1	156	Q86VR8
CGRSSNRLARFADGT	FJX1	161	Q86VR8
NRLARFADGTRACVR	FJX1	166	Q86VR8
NESRRRCADARGASG	NKX3-2	101	P78367
LSRRLCENRRGSLSQ	BOD1L1	1066	Q8NFC6
GTQRRRAICVNTRND	ADAMTS9	1016	Q9P2N4
GVVSCSGVARARARN	CENPB	131	P07199
CERGADVNRGQRSSS	HECTD1	416	Q9ULT8
RTKRGSRGQGSQRCI	FBH1	46	Q8NFZ0
APNDRGCGERRRNTI	GFRA3	221	O60609
SAAFAQRLCLGRNRS	CALHM6	131	Q5R3K3
IECARGACVASRNRR	FUT11	96	Q495W5
GACVASRNRRALRDS	FUT11	101	Q495W5
ESTPRGRCDSRGNQR	CRACD	696	Q6ZU35
RGAAEATSRLRERGC	GARRE1	231	O15063
SCERRNNIGRALDAT	CXCR1	276	P25024
SGSRQDGRRRSGNRN	DDX50	711	Q9BQ39
SCAQARRVTGGLLDR	ANK3	4211	Q12955
SRGNLCVNLMRGRER	C1QB	176	P02746
SSGDRNLERRCRPNL	MBIP	11	Q9NS73
NGDRAACQTRTLRFV	INSRR	476	P14616
GRTECVLSNLRGRTR	EPOR	201	P19235
QRRAGRSGQARAAER	HGSNAT	11	Q68CP4
RRQRSNSCDRGSGQQ	LCE3C	66	Q5T5A8
CRRSNVCTLVRGRQA	ELANE	181	P08246
LGCRAGRQRTRHQKD	EVC	46	P57679
RCILSNRTRRQNLDG	CCDC168	2231	Q8NDH2
RIDISRRGNAGDCLA	GRIA1	311	P42261
GRNNRNEGTLDSRRT	CDKL5	546	O76039
LTLRLVNGSDRCQGR	DMBT1	731	Q9UGM3
SSLALRLVNGGDRCR	DMBT1	1636	Q9UGM3
ALRSRGTATACRLDN	SLC39A13	36	Q96H72
TRNARNCLGGLRNIA	PKD1L1	2321	Q8TDX9
NGGRCREKRRGVTCD	CNTNAP3B	971	Q96NU0
ATARAGGRIRSERCF	PAOX	46	Q6QHF9
RSFRLGCRERLGGSQ	MPP3	341	Q13368
PGDRLRQTENRATRC	MIDN	376	Q504T8
RARARGRARGQETAQ	PIWIL1	6	Q96J94
RKNRTRSHCRLGQAG	RTN4R	421	Q9BZR6
RAAQRRRRVENAGGS	RSAD1	16	Q9HA92
GRQAGRRCRGRLFQT	TAF6L	566	Q9Y6J9
RRRAGCQRKGQISGE	TSGA10IP	266	Q3SY00
RRLTARQSFVDLGCG	TRMT44	351	Q8IYL2
SCNVGIRRRFRAGTA	SSPOP	3001	A2VEC9
SCGGGEQLRSRRCAR	SSPOP	3661	A2VEC9
RSCGGLGTRTRSRQC	SSPOP	3826	A2VEC9
RGDCVREDARRSNGI	TMEM132D	236	Q14C87
RLSCERAGTRFNVRG	SYNJ1	206	O43426
ARFRARECGGNRRIC	UPF3A	446	Q9H1J1
CRQRQRDRGNKSSHG	NBEA	1486	Q8NFP9
LTLAGARAQCRRQGA	NCAN	271	O14594
ARAQCRRQGAALASV	NCAN	276	O14594
ARLSRARAGGTRCPQ	FAM120AOS	61	Q5T036
GKRQRRISAEGSQAC	RSPO1	26	Q2MKA7
RRRGGGSFVERCQEL	SHKBP1	656	Q8TBC3
AAGGNLSSRCVRAAR	SIN3B	921	O75182
RKTDNNRIARACGAR	CCT3	316	P49368
RSRRCVNGPLQEAAR	SH3TC2	61	Q8TF17
RKQQRLSDGCHDRRG	WAC	6	Q9BTA9
GLSEESLQRRCRQRG	MESP1	141	Q9BRJ9
SLQRRCRQRGDAGSP	MESP1	146	Q9BRJ9
AQPQAGRRTRREACT	SP1	591	P08047
QIGARQDRSCTEGAR	RHPN1	226	Q8TCX5
QSRRCQLCAGSGRRR	SSUH2	211	Q9Y2M2
SGRRRCSTCSGRGNK	SSUH2	221	Q9Y2M2
RRVRELGGCSQAGNR	AGFG2	31	O95081
LQSVREGCRTRSQCR	CDCA7	51	Q9BWT1
QAERRSVLRGFCANS	CHST12	121	Q9NRB3
ATRESRCRRGRIGVQ	nan	11	Q9BTK2
QRGRSCDSLNNRCEG	THBS1	401	P07996
SRNCLNRRSRFGSRE	PHLPP2	6	Q6ZVD8
RFGVVRACRENATGR	SPEG	2976	Q15772
VRQRKNASCGTRSAG	SEC61B	31	P60468
RQRRLGQSRASADFG	SAPCD2	266	Q86UD0
RRTVRANGCVANGEV	SPTLC2	11	O15270
RGCTGRNIRQLSLDV	PPAN	36	Q9NQ55
NIRVVRCGGSELNFR	WDR75	6	Q8IWA0
GCGERARAHARQRIS	IGHMBP2	931	P38935
RARACSEQEGRLLGN	STX16	146	O14662
QCSATCGDGVRERRR	THSD1	351	Q9NS62
SRRATRRNSFCNGVT	NEURL1B	56	A8MQ27
SFSDICGGRLALQRR	PIGH	6	Q14442
CSSQRSGRGRGLREF	PRRC2B	1101	Q5JSZ5
RCDNNDTTIIRGRCR	STAB2	1271	Q8WWQ8
GSGSRQREQANVGRR	ROBO1	1611	Q9Y6N7
DRNTRVQVGCRELRS	SOSTDC1	66	Q6X4U4
ERRDRQKGRRAGCDT	nan	6	Q8IYB0
RRGASAAARLGCNRQ	TRIM14	346	Q14142
GRVARAGTRGAQQSR	ZNF598	316	Q86UK7
QPRARFQRCSGRSLS	UTS2R	346	Q9UKP6
QSRRRSQAACCRALG	VWA5B2	76	Q8N398
LTCRRDQRDRRGIGN	ZNF415	166	Q09FC8
GINGQLRSSRFRSIC	TBC1D5	76	Q92609
NRLGVCGRFLSSRVS	TREML1	191	Q86YW5
GGRRCQAQVSRRISF	PTS	6	Q03393
AGQQVSRGARDRVRS	TSC2	1116	P49815
VEAQSRLCGSRRAGR	NECAB3	181	Q96P71